CDC Backs Pfizer Boosters for Those Aged 16-17
THURSDAY, Dec. 9, 2021 (HealthDay News) — The U.S. Centers for Disease Control and Prevention on Thursday backed the emergency approval of Pfizer’s booster shots for Americans aged 16 and 17. The decision came shortly after the U.S. Food and Drug Administration authorized a third dose for that age group;Continue Reading